These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35949224)

  • 1. Quantifying the Benefits of Digital Biomarkers and Technology-Based Study Endpoints in Clinical Trials: Project Moneyball.
    Mori H; Wiklund SJ; Zhang JY
    Digit Biomark; 2022; 6(2):36-46. PubMed ID: 35949224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stride Velocity 95th Centile: Insights into Gaining Regulatory Qualification of the First Wearable-Derived Digital Endpoint for use in Duchenne Muscular Dystrophy Trials.
    Servais L; Yen K; Guridi M; Lukawy J; Vissière D; Strijbos P
    J Neuromuscul Dis; 2022; 9(2):335-346. PubMed ID: 34958044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First Regulatory Qualification of a Novel Digital Endpoint in Duchenne Muscular Dystrophy: A Multi-Stakeholder Perspective on the Impact for Patients and for Drug Development in Neuromuscular Diseases.
    Servais L; Camino E; Clement A; McDonald CM; Lukawy J; Lowes LP; Eggenspieler D; Cerreta F; Strijbos P
    Digit Biomark; 2021; 5(2):183-190. PubMed ID: 34723071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European regulators' views on a wearable-derived performance measurement of ambulation for Duchenne muscular dystrophy regulatory trials.
    Haberkamp M; Moseley J; Athanasiou D; de Andres-Trelles F; Elferink A; Rosa MM; Magrelli A
    Neuromuscul Disord; 2019 Jul; 29(7):514-516. PubMed ID: 31272741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective.
    Stephenson D; Badawy R; Mathur S; Tome M; Rochester L
    J Parkinsons Dis; 2021; 11(s1):S103-S109. PubMed ID: 33579873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digitally Enabled, Patient-Centric Clinical Trials: Shifting the Drug Development Paradigm.
    Dockendorf MF; Hansen BJ; Bateman KP; Moyer M; Shah JK; Shipley LA
    Clin Transl Sci; 2021 Mar; 14(2):445-459. PubMed ID: 33048475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Study of Novel Exploratory Tools, Digital Technologies, and Central Nervous System Biomarkers to Characterize Unipolar Depression.
    Sverdlov O; Curcic J; Hannesdottir K; Gou L; De Luca V; Ambrosetti F; Zhang B; Praestgaard J; Vallejo V; Dolman A; Gomez-Mancilla B; Biliouris K; Deurinck M; Cormack F; Anderson JJ; Bott NT; Peremen Z; Issachar G; Laufer O; Joachim D; Jagesar RR; Jongs N; Kas MJ; Zhuparris A; Zuiker R; Recourt K; Zuilhof Z; Cha JH; Jacobs GE
    Front Psychiatry; 2021; 12():640741. PubMed ID: 34025472
    [No Abstract]   [Full Text] [Related]  

  • 9. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital technologies: Innovations that transform the face of drug development.
    Izmailova ES; AbuAsal B; Hassan HE; Saha A; Stephenson D
    Clin Transl Sci; 2023 Aug; 16(8):1323-1330. PubMed ID: 37157935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Business analysis for a sustainable, multi-stakeholder ecosystem for leveraging the Electronic Health Records for Clinical Research (EHR4CR) platform in Europe.
    Dupont D; Beresniak A; Sundgren M; Schmidt A; Ainsworth J; Coorevits P; Kalra D; Dewispelaere M; De Moor G
    Int J Med Inform; 2017 Jan; 97():341-352. PubMed ID: 27919393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein.
    Merchant KM; Cedarbaum JM; Brundin P; Dave KD; Eberling J; Espay AJ; Hutten SJ; Javidnia M; Luthman J; Maetzler W; Menalled L; Reimer AN; Stoessl AJ; Weiner DM;
    J Parkinsons Dis; 2019; 9(1):31-61. PubMed ID: 30400107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digital Game Interventions for Youth Mental Health Services (Gaming My Way to Recovery): Protocol for a Scoping Review.
    Ferrari M; McIlwaine SV; Reynolds JA; Archie S; Boydell K; Lal S; Shah JL; Henderson J; Alvarez-Jimenez M; Andersson N; Boruff J; Nielsen RKL; Iyer SN
    JMIR Res Protoc; 2020 Jun; 9(6):e13834. PubMed ID: 32579117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a Novel Measurement of Sleep in Rheumatoid Arthritis: Study Proposal for Approach and Considerations.
    Crouthamel M; Mather RJ; Ramachandran S; Bode K; Chatterjee G; Garcia-Gancedo L; Kim J; Alaj R; Wipperman MF; Leyens L; Sillen H; Murphy T; Benecky M; Maggio B; Switzer T
    Digit Biomark; 2021; 5(3):191-205. PubMed ID: 34703974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling tool to support decision-making in the NHS Health Check programme: workshops, systematic review and co-production with users.
    O'Flaherty M; Lloyd-Williams F; Capewell S; Boland A; Maden M; Collins B; Bandosz P; Hyseni L; Kypridemos C
    Health Technol Assess; 2021 May; 25(35):1-234. PubMed ID: 34076574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations for Conducting Bring Your Own "Device" (BYOD) Clinical Studies.
    Demanuele C; Lokker C; Jhaveri K; Georgiev P; Sezgin E; Geoghegan C; Zou KH; Izmailova E; McCarthy M
    Digit Biomark; 2022; 6(2):47-60. PubMed ID: 35949223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enabling breakthroughs in Parkinson's disease with wearable technologies and big data analytics.
    Cohen S; Bataille LR; Martig AK
    Mhealth; 2016; 2():20. PubMed ID: 28293596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital Biomarkers of Mobility in Parkinson's Disease During Daily Living.
    Shah VV; McNames J; Mancini M; Carlson-Kuhta P; Nutt JG; El-Gohary M; Lapidus JA; Horak FB; Curtze C
    J Parkinsons Dis; 2020; 10(3):1099-1111. PubMed ID: 32417795
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.